chevron_leftBack
As of 20 June 2026, Genpharmasec Ltd. has a market cap of $7.27M USD, ranking #42894 globally and #3552 in India.
It ranks #5064 in the Basic Materials sector, and #1218 in the Specialty Chemicals industry.
Key Stats
Market Cap
$7.27MUSD
686.61M INR
Enterprise Value
$7.9MUSD
745.44M INR
Revenue (TTM)
$10.44MUSD
985.18M INR
EBITDA (TTM)
-$307.86KUSD
-29.07M INR
Net Income (TTM)
-$48.55KUSD
-4.58M INR
EBITDA Margin
-3%
Profit Margin
-0.5%
PS Ratio
0.7
PB Ratio
1.0
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
10
Founded
1992
Website
genpharmasec.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -4.6% | 8.3% | 55% | 11% | -27% | -37% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
531592
(GENPHARMA)
Genpharmasec Ltd
ISIN: INE861N01036
Shares Out.:
Shares Outstanding:
553.72M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.24 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Genpharmasec Ltd.
Genpharmasec Limited buys, sells, and distributes pharmaceutical activities and services in India. The company operates through two segments, Diagnostic Pharma Equipment, and Investment and Trading in Securities. The Diagnostic Pharma Equipment segment distributes state-of-the-art diagnostic equipment comprising of i-STAT analyzers and its cartridges used to analyze blood for test results in Intensive Care Units (ICUs) of hospitals. The Investment and Trading in Securities segment operates in secondary securities market. The company was formerly known as Generic Pharmasec Limited and changed its name to Genpharmasec Limited in October 2021. Genpharmasec Limited was incorporated in 1992 and is based in Mumbai, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: ASIANPAINT
|
$24.84B
341K%
2.34T INR
|
60.9
|
|
NSE: PIDILITIND
|
$14.83B
204K%
1.4T INR
|
61.2
|
|
NSE: SOLARINDS
|
$14.74B
203K%
1.39T INR
|
95.8
|
|
NSE: SRF
|
$7.99B
110K%
753.87B INR
|
42.4
|
|
NSE: LINDEINDIA
|
$6.6B
91K%
623.41B INR
|
105.7
|
|
NSE: COROMANDEL
|
$6.28B
86K%
592.36B INR
|
24.7
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
|
NASDAQ: LIN
|
$233.88B
3M%
|
34.5
|
|
EPA: AI
|
$120.09B
2M%
104.79B EUR
|
29.9
|
|
TSE: 4063
|
$81.32B
1M%
13.15T JPY
|
28.0
|
|
NYSE: SHW
|
$77.94B
1M%
|
30.5
|
|
NYSE: ECL
|
$72.47B
996K%
|
34.7
|
|
NYSE: APD
|
$67.35B
926K%
|
-
|
chevron_leftBack